# A Benefit Population Atlas of nICT Versus nCT for LAGC

> **NCT07098104** · — · COMPLETED · sponsor: **Cheng Chen** · enrollment: 291 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT07098104
- **Lead sponsor:** Cheng Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-05-01
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07098104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07098104, "A Benefit Population Atlas of nICT Versus nCT for LAGC". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT07098104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*